Matches in SemOpenAlex for { <https://semopenalex.org/work/W2987051322> ?p ?o ?g. }
- W2987051322 abstract "Abstract Parkinson’s disease (PD) is a prevalent neurodegenerative disease with no approved disease-modifying therapies. Multiplications, mutations, and single nucleotide polymorphisms in the SNCA gene, encoding alpha-synuclein protein (aSyn), either cause or increase risk for PD. Intracellular accumulations of aSyn are pathological hallmarks of PD. Taken together, reduction of aSyn production may provide a disease-modifying therapy for PD. We show that antisense oligonucleotides (ASOs) reduce production of aSyn in rodent pre-formed fibril (PFF) models of PD. Reduced aSyn production leads to prevention and removal of established aSyn pathology and prevents dopaminergic cell dysfunction. In addition, we address the translational potential of the approach through characterization of human SNCA targeting ASOs that efficiently suppress the human SNCA transcript in vivo. We demonstrate broad activity and distribution of the human SNCA ASOs throughout the non-human primate brain and a corresponding decrease in aSyn cerebral spinal fluid (CSF) levels. Taken together, these data suggest that by inhibiting production of aSyn it may be possible to reverse established pathology and thus supports the development of SNCA ASOs as a potentially disease modifying therapy for PD and related synucleinopathies. Summary Antisense oligonucleotides designed against SNCA , which are progressing to the clinic, have the potential to be a disease modifying therapeutic for Parkinson’s disease patients." @default.
- W2987051322 created "2019-11-22" @default.
- W2987051322 creator A5004121845 @default.
- W2987051322 creator A5005463907 @default.
- W2987051322 creator A5009098620 @default.
- W2987051322 creator A5011997502 @default.
- W2987051322 creator A5014465543 @default.
- W2987051322 creator A5016766426 @default.
- W2987051322 creator A5017344762 @default.
- W2987051322 creator A5022859761 @default.
- W2987051322 creator A5026208351 @default.
- W2987051322 creator A5046566422 @default.
- W2987051322 creator A5046921947 @default.
- W2987051322 creator A5048956203 @default.
- W2987051322 creator A5049280339 @default.
- W2987051322 creator A5055351165 @default.
- W2987051322 creator A5062794092 @default.
- W2987051322 creator A5063334368 @default.
- W2987051322 creator A5064417531 @default.
- W2987051322 creator A5068387084 @default.
- W2987051322 creator A5075758381 @default.
- W2987051322 creator A5080357515 @default.
- W2987051322 creator A5080392411 @default.
- W2987051322 creator A5083296071 @default.
- W2987051322 creator A5086053572 @default.
- W2987051322 creator A5086840387 @default.
- W2987051322 creator A5087337344 @default.
- W2987051322 date "2019-11-04" @default.
- W2987051322 modified "2023-09-27" @default.
- W2987051322 title "Alpha-synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson’s disease" @default.
- W2987051322 cites W1502551601 @default.
- W2987051322 cites W1527671059 @default.
- W2987051322 cites W169228635 @default.
- W2987051322 cites W1786270771 @default.
- W2987051322 cites W1897859562 @default.
- W2987051322 cites W1918258073 @default.
- W2987051322 cites W1965095016 @default.
- W2987051322 cites W1965778124 @default.
- W2987051322 cites W1972601084 @default.
- W2987051322 cites W1979527613 @default.
- W2987051322 cites W1979786105 @default.
- W2987051322 cites W1984325684 @default.
- W2987051322 cites W1985013843 @default.
- W2987051322 cites W1985034219 @default.
- W2987051322 cites W1989913002 @default.
- W2987051322 cites W1997188614 @default.
- W2987051322 cites W2003181166 @default.
- W2987051322 cites W2011473770 @default.
- W2987051322 cites W2011754722 @default.
- W2987051322 cites W2028806152 @default.
- W2987051322 cites W2032426626 @default.
- W2987051322 cites W2047565527 @default.
- W2987051322 cites W2058894111 @default.
- W2987051322 cites W2060222606 @default.
- W2987051322 cites W2070726342 @default.
- W2987051322 cites W2081032574 @default.
- W2987051322 cites W2084910880 @default.
- W2987051322 cites W2085082653 @default.
- W2987051322 cites W2085898938 @default.
- W2987051322 cites W2089522371 @default.
- W2987051322 cites W2091265794 @default.
- W2987051322 cites W2092791231 @default.
- W2987051322 cites W2093415544 @default.
- W2987051322 cites W2115222513 @default.
- W2987051322 cites W2116766274 @default.
- W2987051322 cites W2122688529 @default.
- W2987051322 cites W2123431154 @default.
- W2987051322 cites W2128739333 @default.
- W2987051322 cites W2130453306 @default.
- W2987051322 cites W2130886644 @default.
- W2987051322 cites W2135384228 @default.
- W2987051322 cites W2141459724 @default.
- W2987051322 cites W2143695226 @default.
- W2987051322 cites W2148641246 @default.
- W2987051322 cites W2149522871 @default.
- W2987051322 cites W2153899872 @default.
- W2987051322 cites W2154737306 @default.
- W2987051322 cites W2157559454 @default.
- W2987051322 cites W2164627569 @default.
- W2987051322 cites W2166374868 @default.
- W2987051322 cites W2168432448 @default.
- W2987051322 cites W2171281715 @default.
- W2987051322 cites W2178984859 @default.
- W2987051322 cites W2192217112 @default.
- W2987051322 cites W2271618092 @default.
- W2987051322 cites W2300951885 @default.
- W2987051322 cites W2338408645 @default.
- W2987051322 cites W2417395660 @default.
- W2987051322 cites W2557770353 @default.
- W2987051322 cites W2560202024 @default.
- W2987051322 cites W2578596646 @default.
- W2987051322 cites W2582711285 @default.
- W2987051322 cites W2586762519 @default.
- W2987051322 cites W2591558604 @default.
- W2987051322 cites W2606911774 @default.
- W2987051322 cites W2617090960 @default.
- W2987051322 cites W2618767189 @default.
- W2987051322 cites W2734347586 @default.
- W2987051322 cites W2739317540 @default.
- W2987051322 cites W2743091325 @default.